CIK: 1687880 - Address: One Sansome Street, Suite 1650, San Francisco, CA 94104
31 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/30/24 16:35
10/28/24
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-1,4919.440-158-35,653M
9/24/24 16:40
9/20/24
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-7,3956.530-1,133-147,197D
9/13/24 18:44
9/11/24
GLUEMonte Rosa Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-3,4056.000-567-68,330D
8/30/24 16:16
8/28/24
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-1,4016.320-222-36,207D
8/12/24 20:33
8/8/24
TPSTTempest Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-9671.230-788-183,507D
8/11/22 16:55
8/9/22
IPSCCentury Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-7,16713.030-550-412,166D
10/20/21 16:38
10/18/21
OYSTOyster Point Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-8,16114.840-550-143,246I
12/1/20 19:13
11/30/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-34533.150-1005,606M
11/23/20 16:41
11/19/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-4,29233.010-130-27,647M
11/19/20 21:19
11/17/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-15633.050-507,777M
11/17/20 19:33
11/13/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-15933.740-507,782M
11/13/20 19:47
11/12/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS-53334.150-1605,927M
11/12/20 17:41
11/10/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-1,35034.110-4008,752M
11/10/20 19:24
11/6/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-31133.080-908,791M
11/6/20 16:44
11/4/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-37633.140-1108,801M
10/28/20 17:58
10/26/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-29633.280-908,812M
10/20/20 20:09
10/15/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-52733.440-1608,821M
10/15/20 19:22
10/13/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-57433.300-1708,837M
10/13/20 19:41
10/8/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-75833.500-2308,854M
10/8/20 19:14
10/6/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-1,53633.440-46-15,757M
8/12/20 19:57
8/10/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVersant Venture Capital Vi, L.P.CATS.m-45633.060-14010,541M
7/10/20 20:28
1/7/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.am-1,06119.990-53-22,847I
7/10/20 20:28
1/2/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.am-1,42719.700-72-22,900I
1/21/20 21:57
1/16/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-1,24220.870-60-23,093I
1/15/20 21:53
1/10/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-1,01920.040-51-23,152I
1/9/20 20:11
1/7/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-1,06119.990-53-23,203I
1/6/20 20:59
1/2/20
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-1,42719.700-72-23,256I
12/31/19 19:11
12/27/19
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.am-9,42124.200-389-103,657D
12/31/19 18:05
12/27/19
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-9,42124.200-389-103,657D
12/26/19 20:59
12/20/19
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-1,05021.340-49-14,046D
12/19/19 21:30
12/17/19
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVersant Venture Capital Vi, L.P.CATS.m-18919.560-1004,095D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact